Mette Heiskanen

7PUBLICATIONS
23CO-AUTHORS
Medical infection agents (incl. prions)Peripheral nervous systemNeural engineeringCentral nervous systemMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 11, 2024
Plasma microRNAs as prognostic biomarkers for development of severe epilepsy after experimental traumatic brain injury-EpiBioS4Rx Project 1 study.

Mette Heiskanen, Xavier Ekolle Ndode-Ekane, Idrish Ali

|Oct 14, 2024
Plasma neurofilament heavy chain is a prognostic biomarker for the development of severe epilepsy after experimental traumatic brain injury.

Mette Heiskanen, Ivette Banuelos, Eppu Manninen

|Feb 11, 2023
Discovery and Validation of Circulating microRNAs as Biomarkers for Epileptogenesis after Experimental Traumatic Brain Injury-The EPITARGET Cohort.

Mette Heiskanen, Shalini Das Gupta, James D Mills

|Dec 11, 2022
Plasma Neurofilament Light Chain (NF-L) Is a Prognostic Biomarker for Cortical Damage Evolution but Not for Cognitive Impairment or Epileptogenesis Following Experimental TBI.

Mette Heiskanen, Olli Jääskeläinen, Eppu Manninen

|Feb 09, 2021
Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain Injury.

Shalini Das Gupta, Robert Ciszek, Mette Heiskanen

|May 28, 2020
Increased expression of miR142 and miR155 in glial and immune cells after traumatic brain injury may contribute to neuroinflammation via astrocyte activation.

Anatoly Korotkov, Noora Puhakka, Shalini Das Gupta

Pageof 2

Frequent Collaborators

5 joint publications

Asla Pitkänen

3 joint publications

Eppu Manninen

2 joint publications

Noora Puhakka

2 joint publications

Pedro Andrade